Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

ON Semiconductor Stock (NASDAQ: ON) Week Ahead Outlook: Nasdaq-100 Exit, Buybacks, and GaN Catalysts to Watch (Dec. 22–26, 2025)

ON Semiconductor Stock (NASDAQ: ON) Week Ahead Outlook: Nasdaq-100 Exit, Buybacks, and GaN Catalysts to Watch (Dec. 22–26, 2025)

Date: Sunday, December 21, 2025 ON Semiconductor Corporation (onsemi) heads into a holiday-shortened trading week with two unusual forces likely to dominate price action: (1) index-driven flows tied to ON’s removal from the Nasdaq-100, and (2) a steady drumbeat of strategic announcements aimed at power semiconductors for AI infrastructure, EVs, and industrial energy systems. As of the latest close, ON stock finished at $55.21. StockAnalysisWhile fundamentals matter over time, the coming week could be shaped by liquidity (thin holiday trading), rebalancing mechanics, and headline sensitivity—especially around onsemi’s expanding presence in gallium nitride (GaN) and silicon carbide (SiC) power devices. Below
Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) heads into the week of December 22–26, 2025 with a familiar setup for biotech investors: a cash-rich market leader in cystic fibrosis (CF), a pipeline that could meaningfully diversify revenue over the next 12–24 months, and a stock that can move quickly on headlines—even when broader markets are quiet. The difference this time is the calendar. U.S. equities trading will be compressed by Christmas, with an early close on Wednesday, Dec. 24 (1:00 p.m. ET) and markets closed Thursday, Dec. 25. That tends to thin liquidity and can magnify price swings—up or down—on even modest
22 December 2025
Linde plc (LIN) Stock Week Ahead: Latest News, Analyst Forecasts and Key Catalysts for Dec 22–26, 2025

Linde plc (LIN) Stock Week Ahead: Latest News, Analyst Forecasts and Key Catalysts for Dec 22–26, 2025

As of Sunday, December 21, 2025, Linde plc (ticker: LIN) enters a holiday-shortened trading week with a familiar setup: macro headlines and interest-rate expectations are likely to drive near-term sentiment, while Linde’s long-term narrative—pricing discipline, contract-backed backlog, and capital returns—continues to anchor many bullish analyst views. LIN last closed at $421.42 on Friday, Dec. 19 (U.S. session). linde.com Below is a detailed week-ahead briefing built from the most current news, filings, forecasts, and analyst commentary available up to 21.12.2025. What’s new around Linde stock right now 1) Linde’s Q3 results: earnings beat, cautious near-term tone The most recent quarterly update
Analog Devices (ADI) Stock Week Ahead: Holiday-Shortened Trading, Fresh Price-Target Hikes, and Key Catalysts for Dec. 22–26, 2025

Analog Devices (ADI) Stock Week Ahead: Holiday-Shortened Trading, Fresh Price-Target Hikes, and Key Catalysts for Dec. 22–26, 2025

Analog Devices, Inc. (NASDAQ: ADI) heads into the Christmas week with investors balancing three storylines: a holiday-shortened trading schedule, a run of upbeat sell-side revisions, and new industry chatter about pricing power heading into 2026. As of the last full trading session before this report, ADI ended Friday, December 19, 2025, at $274.44, after a choppy week that included a midweek slide and a rebound attempt into the close. ADI remains not far from its 52-week high of $284.23, leaving the stock in a “near-the-top, but not breaking out” posture going into thin holiday liquidity. Investing.com Below is what matters
Coca-Cola (KO) Stock Week Ahead (Dec 22–26, 2025): CEO Succession, Costa Coffee Sale Talks, Analyst Targets, and Key Levels to Watch

Coca-Cola (KO) Stock Week Ahead (Dec 22–26, 2025): CEO Succession, Costa Coffee Sale Talks, Analyst Targets, and Key Levels to Watch

As the new week begins (Monday, December 22, 2025), The Coca-Cola Company (The) (NYSE: KO) heads into a holiday-shortened stretch with the stock hovering around $70 and investors weighing a mix of corporate headlines, analyst updates, and a macro calendar that could sway defensive names. KO last traded around $70.06 heading into the weekend, keeping the beverage giant firmly in “steady compounder” territory as markets prepare for lighter liquidity around Christmas. Below is what matters most for Coca-Cola stock in the week ahead, including the latest newsflow as of 21.12.2025, what analysts are forecasting, and the technical and macro levels
22 December 2025
Sandisk (SNDK) Stock Week Ahead: AI-Driven NAND Tightness, Analyst Targets, and Key Catalysts for Dec. 22–26, 2025

Sandisk (SNDK) Stock Week Ahead: AI-Driven NAND Tightness, Analyst Targets, and Key Catalysts for Dec. 22–26, 2025

Date: Sunday, December 21, 2025Ticker: Sandisk Corporation (NASDAQ: SNDK) Sandisk stock heads into the final full holiday stretch of 2025 with momentum, volatility, and a growing spotlight from both Wall Street and index investors. The latest available quote shows SNDK around $237.61 (with the most recent session showing a wide $219.22–$243.67 range), underscoring how quickly sentiment has been swinging in the memory-and-storage trade. This coming week is shorter—U.S. markets close early on Christmas Eve and shut entirely on Christmas Day—so liquidity can thin out and intraday moves can become exaggerated. At the same time, several macro releases land before the
Coinbase (COIN) Stock Week Ahead: Stock-Trading Rollout, Prediction-Market Lawsuits, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

Coinbase (COIN) Stock Week Ahead: Stock-Trading Rollout, Prediction-Market Lawsuits, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

NEW YORK — Sunday, Dec. 21, 2025. Coinbase Global, Inc. (NASDAQ: COIN) heads into the Christmas-shortened trading week with investor attention split between two forces: the crypto tape (bitcoin and broader risk sentiment) and Coinbase’s accelerating push to become an “everything exchange” spanning crypto, stocks, derivatives, and prediction markets. Coinbase shares ended the last full week at $245.12 on Friday, Dec. 19, after swinging sharply intraday and closing lower than the prior Friday’s $267.46—a weekly decline of about 8% based on closing prices. StockAnalysis Meanwhile, bitcoin was trading around $88,316 over the weekend—still the dominant driver of sentiment for most
Carnival Corporation Stock Week Ahead (CCL): Dividend Return, Record 2025 Earnings, and the Key Catalysts to Watch Into Christmas Week

Carnival Corporation Stock Week Ahead (CCL): Dividend Return, Record 2025 Earnings, and the Key Catalysts to Watch Into Christmas Week

Carnival Corporation stock (NYSE: CCL) heads into the week of Dec. 22–26, 2025 with fresh momentum after a sharp post-earnings jump that pushed shares back toward multi-year highs. The move followed Carnival’s record full-year 2025 performance, a bullish 2026 profit outlook, and a headline-grabbing decision to reinstate its quarterly dividend for the first time since the pandemic-era suspension. Nasdaq+2PR Newswire+2 As of the most recent U.S. close (Friday), CCL finished at about $31.12, up roughly 9.7% on the session, with trading volume far above typical levels—an important detail heading into a holiday-shortened week where lower liquidity can amplify price swings.
KLA Corporation Stock (KLAC) Week Ahead Outlook: Analyst Upgrades, AI Equipment Forecasts, and What to Watch Dec. 22–26, 2025

KLA Corporation Stock (KLAC) Week Ahead Outlook: Analyst Upgrades, AI Equipment Forecasts, and What to Watch Dec. 22–26, 2025

Updated for the week ahead (Dec. 22–26, 2025). KLA Corporation (NASDAQ: KLAC) enters the Christmas-shortened trading week with momentum from fresh Wall Street upgrades and a strengthening top-down narrative: the AI infrastructure buildout is keeping semiconductor capital spending—especially at the leading edge—firm into 2026 and 2027. Investing.com+1 As of the latest available quote, KLAC traded around $1,245.67, up about 1.88% from the prior close, with an intraday range roughly $1,227 to $1,263.60 (latest trade timestamp reflects the most recent market update available at publication time). Below is what’s moving KLA stock now—and the concrete catalysts that could shape KLAC’s next
GE Aerospace Stock Week Ahead: Key Catalysts, Analyst Forecasts, and Fresh News for NYSE:GE (Dec. 22–26, 2025)

GE Aerospace Stock Week Ahead: Key Catalysts, Analyst Forecasts, and Fresh News for NYSE:GE (Dec. 22–26, 2025)

GE Aerospace (NYSE: GE) heads into the Christmas-shortened trading week with shares hovering near record territory after a volatile mid-December tape. The stock closed Friday, December 19 at $307.21, extending a two-day rebound and leaving it just under the $316.67 52-week high set in late October. MarketWatch+1 For investors sizing up GE Aerospace stock in the week ahead (Monday, Dec. 22 through Friday, Dec. 26), the setup is defined by three forces: Below is a week-ahead, publication-ready briefing based on the latest reporting and analyst commentary available as of 21.12.2025. Where GE Aerospace stock stands heading into the holiday week
22 December 2025
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely to hinge less on quarterly fundamentals and more on the probability, timing, and conditions of closing. SEC+1 FOLD last traded around $14.18 (near the offer price), reflecting how quickly the market repriced the shares after the announcement. Investors.com Below is the week-ahead playbook: the latest news as of 21.12.2025, what Wall Street is saying, and the specific catalysts that could
Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Inc. (NASDAQ: BIIB) heads into the Christmas week with its stock hovering just below a recent high, a fresh spike in trading volume, and a narrative that’s increasingly dominated by one question: can the company turn Leqembi’s momentum into a durable growth engine while legacy revenue lines mature and competition intensifies? As of Sunday, December 21, 2025, BIIB is coming off a strong finish to last week—closing Friday, Dec. 19 at $174.80, up 2.88% on the session, with unusually heavy volume for the name. MarketWatch That closing level still sits below the 52-week high of $185.17 (set Nov. 24),

Stock Market Today

Go toTop